BACKGROUND
Governments worldwide have introduced COVID-19 tracing technologies. Taiwan, a world leader in controlling the virus’ spread, has introduced the Taiwan ‘Social Distancing App’ to facilitate COVID-19 contact tracing. However, for these technologies to be effective, they must be accepted and used by the public.
OBJECTIVE
Our study aimed to determine public acceptance for three hypothetical tracing technologies: a centralized Government App, a decentralized Bluetooth App (e.g., Taiwan’s Social Distancing App), and a Telecommunication tracing technology; and model what factors contributed to their acceptance.
METHODS
Four nationally representative surveys were conducted in April 2020 sampling 6,000 Taiwanese residents. Perceptions and impacts of COVID-19, government effectiveness, worldviews, and attitudes towards and acceptance of one-of-three hypothetical tracing technologies were assessed.
RESULTS
Technology acceptance was high across all hypothetical technologies (67% - 73%) and improved with additional privacy measures (82% - 88%). Bayesian modelling (using 95% highest density credible intervals) showed data sensitivity and perceived poor COVID-19 policy compliance inhibited technology acceptance. By contrast, technology benefits (e.g., returning to activities, reducing virus spread, lowering the likelihood of infection), higher education, and perceived technology privacy, security, and trust, were all contributing factors to overall acceptance. Bayesian ordinal probit models revealed higher COVID-19 concern for other people than for one’s self.
CONCLUSIONS
Taiwan is currently using a range of technologies to minimize the spread of COVID-19 as the country returns to normal economic and social activities. We observed high acceptance for COVID-19 tracing technologies among the Taiwanese public, a promising and necessary finding for the successful introduction of Taiwan’s new ‘Social Distancing App’. Policy makers may capitalize on this acceptance by focusing attention towards the App’s benefits, privacy and security measures, making the App’s privacy measures transparent to the public, and emphasizing App uptake and compliance among the public.
CLINICALTRIAL
Not applicable.